Literature DB >> 8314484

Alpha interferon treatment of chronic hepatitis C in beta-thalassaemia.

V Di Marco1, O Lo Iacono, M Capra, S Grutta, C Ciaccio, C Gerardi, A Maggio, D Renda, P Almasio, R Pisa.   

Abstract

In this open, pilot study, interferon (IFN) alpha-2b seemed effective in the treatment of hepatitis C virus (HCV) infection in patients with beta-thalassaemia. In seven of nine patients who completed the study alanine aminotransferase activities returned to normal, and a completely stable response 24 months after treatment was seen in five. Liver biopsy specimen showed a clear reduction in portal, periportal, and lobular necroinflammation in all five cases. Three patients stopped treatment early because of side effects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8314484      PMCID: PMC1374044          DOI: 10.1136/gut.34.2_suppl.s142

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  3 in total

Review 1.  Treatment of Chronic HCV Infection in Patients With Thalassemia.

Authors:  Halim Bou Daher; Ala I Sharara
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-01-29

2.  Hepatocellular carcinoma in thalassemia: A critical review.

Authors:  Andrea Mancuso
Journal:  World J Hepatol       Date:  2010-05-27

Review 3.  Safety and Efficacy of Adding Ribavirin to Interferon or Peginterferon in Treatment of Hepatitis C Infection in Patients With Thalassemia: A Systematic Review on Randomized Controlled Trials.

Authors:  Ehsan Aminizadeh; Seyed Moayyed Alavian; Ali Akbari Sari; Nasser Ebrahimi Daryani; Bita Behnava
Journal:  Hepat Mon       Date:  2016-03-06       Impact factor: 0.660

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.